Literature DB >> 32047276

Recognizing hypoxia in phaeochromocytomas and paragangliomas.

Patricia L M Dahia1, Rodrigo A Toledo2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32047276     DOI： 10.1038/s41574-020-0324-1

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  4 in total

Review 1.  Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers.

Authors:  Shahida K Flores; Cynthia M Estrada-Zuniga; Keerthi Thallapureddy; Gustavo Armaiz-Peña; Patricia L M Dahia
Journal:  Cancers (Basel)       Date:  2021-09-14       Impact factor: 6.575

Review 2.  Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?

Authors:  Camilo Jimenez; Gustavo Armaiz-Pena; Patricia L M Dahia; Yang Lu; Rodrigo A Toledo; Jeena Varghese; Mouhammed Amir Habra
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

3.  Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.

Authors:  Takao Kamai; Satoshi Murakami; Kyoko Arai; Daisaku Nishihara; Toshitaka Uematsu; Kazuyuki Ishida; Toshiki Kijima
Journal:  BMC Cancer       Date:  2022-03-18       Impact factor: 4.430

4.  CRHR1 mediates the transcriptional expression of pituitary hormones and their receptors under hypoxia.

Authors:  Tong Ying Wang; Fang Yuan Xia; Jing Wen Gong; Xiao Kang Xu; Min Chao Lv; Mahanand Chatoo; Bilal Haider Shamsi; Meng Chen Zhang; Qian Ru Liu; Tian Xing Liu; Dan Dan Zhang; Xin Jiang Lu; Yang Zhao; Ji Zeng Du; Xue Qun Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.